Where Does BELLUS Health Inc (BLU) Stock Fall in the Biotechnology Field After It Has Risen 0.14% This Week?

Monday, June 26, 2023 01:50 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does BELLUS Health Inc (BLU) Stock Fall in the Biotechnology Field After It Has Risen 0.14% This Week?

The 70 rating InvestorsObserver gives to BELLUS Health Inc (BLU) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 84 percent of stocks in the Biotechnology industry, BLU’s 70 overall rating means the stock scores better than 70 percent of all stocks.

BLU has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on BLU!

See Full BLU Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 70 means the stock is more attractive than 70 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With BELLUS Health Inc Stock Today?

BELLUS Health Inc (BLU) stock is up 0.1% while the S&P 500 has fallen -0.19% as of 1:50 PM on Monday, Jun 26. BLU has gained $0.02 from the previous closing price of $14.73 on volume of 3,001,486 shares. Over the past year the S&P 500 has risen 11.28% while BLU has gained 62.27%. BLU lost -$0.72 per share the over the last 12 months. Click Here to get the full Stock Report for BELLUS Health Inc stock.